Boltzmann Maps provides you, a drug researcher, with tools to design and prioritize small molecules in pre-clinical drug discovery. You identify candidates by visualizing how and why compounds interact with target proteins, and by exploring suggested compound modifications derived from chemical fragment binding maps. The result is higher affinity and more selective compounds that specifically exploit details of binding sites of a particular protein. Boltzmann Maps is low-cost, easy-to-learn, and available everywhere via the Web. Our mission is to enable you to progress novel, high-quality New Chemical Entities to the clinic, faster.
Introducing Gibbs: BMaps’ new AI assistant simplifies drug discovery by answering questions, guiding workflows, and accelerating research—turning hours of learning into minutes. Learn More >>
New: Biomolecular folding with Boltz-1 and Chai-1 The Boltzmann Maps web app now supports predicting biomolecular structure and ligand binding with the AI folding programs Boltz-1 and Chai-1. The resulting structures are prepared for modeling by the BMaps server and are ready for tasks such as energy minimization and docking. Learn More >>